JAGX
NASDAQ
$1.26
Jaguar Health Inc (JAGX)
Jaguar Health, Inc., a commercial-stage pharmaceutical company, focuses on developing prescription drugs for people and animals with gastrointestinal upset, specifically chronic debilitating diarrhea. The company is headquartered in San Francisco, California.
Sector:
Healthcare
Industry:
Biotechnology
Target: $262.50 (+20733.33%)
Market Cap
$1.34M
Price Chart
Valuation
Market Cap$1.34M
Forward P/E200.00
P/S0.30
P/B1.23
Profitability
Total Revenue (TTM)$12M
Gross Profit (TTM)$25M
EBITDA-$30M
Operating Margin-234.8%
EPS-$44.21
Growth & Risk
Revenue 5Y CAGR+7.22%
FCF 5Y CAGR+12.62%
Sharpe Ratio-1.76